Bronchiolitis is one of the most common reasons for pediatric hospitalization in the United
States, incurring costs of $734 million each year. 1 Supportive care is the mainstay of …

Inpatient bronchiolitis outcomes in North America have changed substantially during the
past 4 decades. Annual deaths associated with bronchiolitis in the United States were once …

BACKGROUND AND OBJECTIVES There is a paucity of multicenter data on rates of high
flow nasal cannula (HFNC) usage in bronchiolitis in the United States, largely because of …

The proliferationof observational literature on the topic of high-flow nasal cannula (HFNC) as
a therapy for acute viral bronchiolitis is nothing short of remarkable. A brief PubMed search …

Bronchiolitis remains the single most common cause of hospitalization during the first year of
life. 1 Although supportive treatment is the cornerstone of bronchiolitis therapy, with …

BACKGROUND High-flow nasal cannula oxygen therapy (HFNC) is increasingly used to
treat bronchiolitis. However, HFNC has not reduced time on supplemental oxygen, length of …

OBJECTIVE: The goal of this study was to assess the association of the introduction of a
ward's high-flow nasal cannula (HFNC) guideline with clinical outcomes of infants with …

OBJECTIVES: High flow nasal cannula (HFNC) is increasingly used for children hospitalized
with bronchiolitis. We aimed to validate identification of HFNC use in a national database …

BACKGROUND AND OBJECTIVES High-flow nasal cannula (HFNC) in children
hospitalized with bronchiolitis does not significantly improve clinical outcomes but can …

Bronchiolitis is among the most common pediatric illnesses, and accounts for a significant
burden of disease for children and families with large economic burden on the United States …